Ronghui Lin

1.1k total citations
34 papers, 908 citations indexed

About

Ronghui Lin is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Ronghui Lin has authored 34 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Ronghui Lin's work include Cancer-related Molecular Pathways (5 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Mechanisms and Therapy (4 papers). Ronghui Lin is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Mechanisms and Therapy (4 papers). Ronghui Lin collaborates with scholars based in United States, China and Belgium. Ronghui Lin's co-authors include Peter J. Connolly, Stuart L. Emanuel, Steven A. Middleton, Angel R. Fuentes‐Pesquera, Yanhua Lü, Shenlin Huang, Steven K. Wetter, Yang Yu, George Chiu and Shengjian Li and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Scientific Reports.

In The Last Decade

Ronghui Lin

32 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronghui Lin United States 13 573 269 191 77 63 34 908
Robert T. Lum United States 16 329 0.6× 332 1.2× 135 0.7× 58 0.8× 21 0.3× 19 759
Achim Schlapbach Switzerland 20 523 0.9× 467 1.7× 206 1.1× 37 0.5× 42 0.7× 29 1.1k
Francis X. Tavares United States 17 453 0.8× 345 1.3× 192 1.0× 39 0.5× 71 1.1× 34 862
Mark A. Ashwell United Kingdom 18 423 0.7× 556 2.1× 206 1.1× 30 0.4× 68 1.1× 39 1.2k
Rob Howes United Kingdom 13 420 0.7× 578 2.1× 118 0.6× 116 1.5× 121 1.9× 14 1.1k
Prabhu Thirusangu India 20 343 0.6× 430 1.6× 186 1.0× 51 0.7× 64 1.0× 35 879
Joseph S. Warmus United States 19 493 0.9× 448 1.7× 113 0.6× 27 0.4× 73 1.2× 38 962
Nozomu Koyanagi Japan 12 571 1.0× 614 2.3× 247 1.3× 65 0.8× 59 0.9× 18 1.0k
Pathik S. Brahmkshatriya India 13 449 0.8× 326 1.2× 157 0.8× 152 2.0× 44 0.7× 28 844
Céline Cano United Kingdom 21 369 0.6× 834 3.1× 387 2.0× 95 1.2× 106 1.7× 54 1.3k

Countries citing papers authored by Ronghui Lin

Since Specialization
Citations

This map shows the geographic impact of Ronghui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronghui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronghui Lin more than expected).

Fields of papers citing papers by Ronghui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronghui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronghui Lin. The network helps show where Ronghui Lin may publish in the future.

Co-authorship network of co-authors of Ronghui Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ronghui Lin. A scholar is included among the top collaborators of Ronghui Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronghui Lin. Ronghui Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roque, Jose B., et al.. (2025). Alkene Borylation–Hydrogenation Enables Highly Active, Site-Selective Cobalt-Catalyzed Borylation. Journal of the American Chemical Society. 147(30). 26437–26445. 1 indexed citations
2.
Chen, Shushang, Ronghui Lin, Junjie Wei, et al.. (2024). The inhibition effect of psoralen on prostate cancer PC3 cells via down-regulation of long non-coding RNA ENST00000510619. Translational Andrology and Urology. 13(10). 2294–2306.
3.
Lin, Ronghui, et al.. (2023). Person Re-Identification Method Based on Dual Descriptor Feature Enhancement. Entropy. 25(8). 1154–1154. 1 indexed citations
4.
Lin, Ronghui, et al.. (2023). Joint Modal Alignment and Feature Enhancement for Visible-Infrared Person Re-Identification. Sensors. 23(11). 4988–4988. 1 indexed citations
5.
Lagatie, Ole, Maurice R. Odiere, Yenny Djuardi, et al.. (2020). 2-Methyl-pentanoyl-carnitine (2-MPC): a urine biomarker for patent Ascaris lumbricoides infection. Scientific Reports. 10(1). 15780–15780. 13 indexed citations
6.
Lin, Yongquan, et al.. (2018). MicroRNA‑539 inhibits cell proliferation, colony formation and invasion in pancreatic ductal adenocarcinoma by directly targeting IGF‑1R. Molecular Medicine Reports. 18(2). 1804–1811. 2 indexed citations
7.
Mamidi, Rao N. V. S., Filip Cuyckens, Jie Chen, et al.. (2014). Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition. 42(5). 903–916. 56 indexed citations
8.
Lin, Ronghui & Larry E. Weaner. (2012). Facile synthesis of stable isotope‐labeled antibacterial agent RWJ‐416457 and its metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. 55(8). 296–299. 1 indexed citations
9.
Lin, Ronghui, Sigmond G. Johnson, Peter J. Connolly, et al.. (2009). Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2333–2337. 112 indexed citations
10.
Sauvaud, J. A., et al.. (2007). Dynamic Response of the far Tail of the Earth Magnetosphere to IMF Changes and Magnetospheric Activity: a STEREO View. AGU Fall Meeting Abstracts. 2007.
11.
12.
Lin, Ronghui, George Chiu, Yang Yu, et al.. (2007). Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4557–4561. 111 indexed citations
13.
Lin, Ronghui, Peter J. Connolly, Yanhua Lü, et al.. (2007). Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents. Bioorganic & Medicinal Chemistry Letters. 17(15). 4297–4302. 75 indexed citations
14.
Hughes, Terry V., Stuart L. Emanuel, Steven K. Wetter, et al.. (2007). 4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 17(12). 3266–3270. 40 indexed citations
15.
Huang, Shenlin, Ronghui Lin, Yang Yu, et al.. (2006). Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor. Bioorganic & Medicinal Chemistry Letters. 17(5). 1243–1245. 101 indexed citations
16.
Huang, Shenlin, et al.. (2006). Synthesis and evaluation of N-acyl sulfonamides as potential prodrugs of cyclin-dependent kinase inhibitor JNJ-7706621. Bioorganic & Medicinal Chemistry Letters. 16(14). 3639–3641. 40 indexed citations
17.
Lin, Ronghui, Yanhua Lü, Steven K. Wetter, et al.. (2005). 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 15(9). 2221–2224. 21 indexed citations
18.
Emanuel, Stuart L., Catherine A. Rugg, Robert H. Gruninger, et al.. (2005). The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases. Cancer Research. 65(19). 9038–9046. 101 indexed citations
19.
LeCouter, Jennifer, Ronghui Lin, & Napoleone Ferrara. (2002). The Role of EG-VEGF in the Regulation of Angiogenesis in Endocrine Glands. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 217–222. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert T. Lum Breakdown of academic impact, for papers by Achim Schlapbach Breakdown of academic impact, for papers by Francis X. Tavares Breakdown of academic impact, for papers by Mark A. Ashwell Breakdown of academic impact, for papers by Rob Howes Breakdown of academic impact, for papers by Prabhu Thirusangu Breakdown of academic impact, for papers by Joseph S. Warmus Breakdown of academic impact, for papers by Nozomu Koyanagi Breakdown of academic impact, for papers by Pathik S. Brahmkshatriya Breakdown of academic impact, for papers by Céline Cano
Rankless by CCL
2026